TrademarkOpen
Search / United States / 90002793

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

CELULARITY

Registered
Used for: bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human…
Show more

Class 1: bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research
Class 5: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimer…

Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplements

Status timeline

  1. 18 Jun 2020
    Application filed
    New Application Entered
  2. 5 Aug 2020
    Assigned to an examining attorney
    Assigned To Examiner
  3. 7 Aug 2020
    Office action issued
    Non-Final Action Written
  4. 15 Sep 2020
    Response to office action filed
    Teas Response To Office Action Received
  5. 9 Oct 2020
    Approved for publication
    Approved For Pub - Principal Register
  6. 17 Nov 2020
    Published for opposition
    Published For Opposition
  7. 2 Feb 2021
    Registered on the Principal Register
    Registered-Principal Register
  8. 12 Jan 2022
    Ownership assignment recorded
    Automatic Update Of Assignment Of Ownership
  9. 7 Jan 2026
    Ownership assignment recorded
    Automatic Update Of Assignment Of Ownership
All 20 events
2026-02-02Rem1
2026-01-07Automatic Update Of Assignment Of Ownership
2022-01-12Automatic Update Of Assignment Of Ownership
2021-02-02Registered-Principal Register
2020-11-17Published For Opposition
2020-11-17Official Gazette Publication Confirmation E-Mailed
2020-10-28Notification Of Notice Of Publication E-Mailed
2020-10-09Approved For Pub - Principal Register
2020-10-08Teas Change Of Owner Address Received
2020-10-08Teas Change Of Correspondence Received
2020-10-08Applicant/Correspondence Changes (Non-Responsive) Entered
2020-09-16Teas/Email Correspondence Entered
2020-09-15Teas Response To Office Action Received
2020-09-15Correspondence Received In Law Office
2020-08-07Non-Final Action Written
2020-08-07Non-Final Action E-Mailed
2020-08-07Notification Of Non-Final Action E-Mailed
2020-08-05Assigned To Examiner
2020-07-14New Application Office Supplied Data Entered
2020-06-18New Application Entered

Goods & services by class

Class 1 Chemicals

bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research

First use anywhere 6 Dec 2018 · First use in commerce 6 Dec 2018

Class 5 Pharmaceuticals & supplements

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimer…

First use anywhere 6 Dec 2018 · First use in commerce 6 Dec 2018

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 3 Feb 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.